Published in Urology on March 01, 2004
Bladder hyperactivity and increased excitability of bladder afferent neurons associated with reduced expression of Kv1.4 alpha-subunit in rats with cystitis. Am J Physiol Regul Integr Comp Physiol (2009) 1.00
Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome. PLoS One (2013) 0.98
Antioxidant effects of green tea and its polyphenols on bladder cells. Life Sci (2008) 0.98
Recent advances in intravesical drug/gene delivery. Mol Pharm (2006) 0.97
The Quantification of Glycosaminoglycans: A Comparison of HPLC, Carbazole, and Alcian Blue Methods. Open Glycosci (2008) 0.96
Cholinergic nitric oxide release from the urinary bladder mucosa in cyclophosphamide-induced cystitis of the anaesthetized rat. Br J Pharmacol (2008) 0.95
Effects of intravesical instillation of resiniferatoxin on bladder function and nociceptive behavior in freely moving, conscious rats. J Urol (2007) 0.95
Expression of fractalkine and fractalkine receptor in urinary bladder after cyclophosphamide (CYP)-induced cystitis. Auton Neurosci (2006) 0.95
Mesenchymal Stem Cell Therapy Alleviates Interstitial Cystitis by Activating Wnt Signaling Pathway. Stem Cells Dev (2015) 0.85
Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis. Int J Urol (2014) 0.85
Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome/interstitial cystitis: long-term treatment results. Int Urogynecol J (2012) 0.84
Exaggerated expression of inflammatory mediators in vasoactive intestinal polypeptide knockout (VIP-/-) mice with cyclophosphamide (CYP)-induced cystitis. J Mol Neurosci (2008) 0.82
Comparison of voiding function and nociceptive behavior in two rat models of cystitis induced by cyclophosphamide or acetone. Neurourol Urodyn (2010) 0.81
Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in Rats. Hum Gene Ther (2015) 0.78
Revisiting the Role of Potassium Sensitivity Testing and Cystoscopic Hydrodistention for the Diagnosis of Interstitial Cystitis. PLoS One (2016) 0.77
Functional role of cannabinoid receptors in urinary bladder. Indian J Urol (2010) 0.76
Nonkeratinised squamous metaplasia of the urinary bladder in children: a report of case experiences. Biomed Res Int (2014) 0.75
Floating Hydrogel with Self-Generating Micro-Bubbles for Intravesical Instillation. Materials (Basel) (2016) 0.75
The effect of intravesical liposome-based NGF antisense therapy on bladder overactivity and nociception in a rat model of cystitis induced by hydrogen peroxide. Hum Gene Ther (2017) 0.75
Comparison of 5 Different Rat Models to Establish a Standard Animal Model for Research Into Interstitial Cystitis. Int Neurourol J (2017) 0.75
Unroofed coronary sinus syndrome: diagnosis, classification, and surgical treatment. J Thorac Cardiovasc Surg (2003) 2.50
Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats. Eur Urol (2008) 2.24
Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci (2004) 1.92
Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates. Urology (2005) 1.81
Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology (2005) 1.77
Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury. Prog Brain Res (2006) 1.74
Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland. J Urol (2006) 1.62
Vascular endothelial growth factor in children with congenital heart disease. Ann Thorac Surg (2003) 1.57
Pathophysiology of urinary incontinence in murine models. Int J Urol (2012) 1.48
Ventricular septal dysfunction after surgical closure of multiple ventricular septal defects. Ann Thorac Surg (2013) 1.47
Appropriate additional pulmonary blood flow at the bidirectional Glenn procedure is useful for completion of total cavopulmonary connection. Ann Thorac Surg (2005) 1.47
Afferent nerve regulation of bladder function in health and disease. Handb Exp Pharmacol (2009) 1.42
Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol (2009) 1.41
Immunoneutralization of nerve growth factor in lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats. J Urol (2002) 1.41
Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia. BJU Int (2006) 1.40
An infected pseudoaneurysm following a modified Blalock-Taussig shunt. Interact Cardiovasc Thorac Surg (2008) 1.39
Inhibitory role of the spinal galanin system in the control of micturition. Urology (2013) 1.39
Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. J Urol (2004) 1.36
Urethral closure mechanisms under sneeze-induced stress condition in rats: a new animal model for evaluation of stress urinary incontinence. Am J Physiol Regul Integr Comp Physiol (2003) 1.32
Transmembrane interaction mediates complex formation between peptidase homologues and Kv4 channels. Mol Cell Neurosci (2005) 1.30
Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy? J Clin Apher (2005) 1.30
The role of bladder-to-urethral reflexes in urinary continence mechanisms in rats. Am J Physiol Renal Physiol (2004) 1.29
Changes in afferent activity after spinal cord injury. Neurourol Urodyn (2010) 1.26
Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target. Neurourol Urodyn (2011) 1.25
An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment. Am J Gastroenterol (2009) 1.24
Suppression of detrusor-sphincter dyssynergia by immunoneutralization of nerve growth factor in lumbosacral spinal cord in spinal cord injured rats. J Urol (2004) 1.24
Efficacy of a criterion-driven transfusion protocol in patients having pediatric cardiac surgery. J Thorac Cardiovasc Surg (2004) 1.22
Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats. Am J Physiol Renal Physiol (2008) 1.20
Evaluation of heart fatty acid-binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery. J Thorac Cardiovasc Surg (2004) 1.18
Role of noradrenergic pathways in sneeze-induced urethral continence reflex in rats. Am J Physiol Renal Physiol (2006) 1.18
Simultaneous repair of pectus excavatum and congenital heart disease over the past 30 years. Eur J Cardiothorac Surg (2002) 1.18
The other bladder syndrome: underactive bladder. Rev Urol (2013) 1.17
Comparison of leak point pressure methods in an animal model of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2005) 1.16
Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats. J Urol (2004) 1.12
Qualitative and quantitative expression profile of muscarinic receptors in human urothelium and detrusor. J Urol (2006) 1.10
Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes. J Urol (2009) 1.09
Reactive oxygen species mediate detrusor overactivity via sensitization of afferent pathway in the bladder of anaesthetized rats. BJU Int (2007) 1.09
Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis. Urology (2008) 1.07
Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium. J Urol (2009) 1.05
Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root Ganglia. J Urol (2002) 1.05
Plasticity in reflex pathways to the lower urinary tract following spinal cord injury. Exp Neurol (2011) 1.05
A tissue-engineered suburethral sling in an animal model of stress urinary incontinence. BJU Int (2005) 1.05
Down-regulation of nerve growth factor expression in the bladder by antisense oligonucleotides as new treatment for overactive bladder. J Urol (2013) 1.02
Detrusor overactivity induced by intravesical application of adenosine 5'-triphosphate under different delivery conditions in rats. Urology (2005) 1.02
A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis. Dig Dis Sci (2006) 1.02
Investigations into the presence of functional Beta1, Beta2 and Beta3-adrenoceptors in urothelium and detrusor of human bladder. Int Braz J Urol (2009) 1.01
Functional analysis of active urethral closure mechanisms under sneeze induced stress condition in a rat model of birth trauma. J Urol (2006) 1.01
Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Hum Gene Ther (2009) 1.01
Bladder hyperactivity and increased excitability of bladder afferent neurons associated with reduced expression of Kv1.4 alpha-subunit in rats with cystitis. Am J Physiol Regul Integr Comp Physiol (2009) 1.00
Impaired neuroanatomic development in infants with congenital heart disease. J Thorac Cardiovasc Surg (2008) 1.00
KW-7158 [(2S)-(+)-3,3,3-trifluoro-2-hydroxy-2-methyl-N-(5,5,10-trioxo-4,10-dihydrothieno[3,2-c][1]benzothiepin-9-yl)propanamide] enhances A-type K+ currents in neurons of the dorsal root ganglion of the adult rat. J Pharmacol Exp Ther (2004) 0.99
Tracheoplasty for long segment congenital tracheal stenosis: analysis of 29 patients over two decades. J Pediatr Surg (2003) 0.99
A model of intrinsic sphincteric deficiency in the rat: electrocauterization. Neurourol Urodyn (2004) 0.98
Instillation of liposomes vs dimethyl sulphoxide or pentosan polysulphate for reducing bladder hyperactivity. BJU Int (2009) 0.98
Antioxidant effects of green tea and its polyphenols on bladder cells. Life Sci (2008) 0.98
GABA receptor activation in the lumbosacral spinal cord decreases detrusor overactivity in spinal cord injured rats. J Urol (2008) 0.98
Implications of diabetes mellitus in urology. Urol Clin North Am (2003) 0.97
Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes (2004) 0.97
Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. J Urol (2008) 0.97
The efficacy of preoperative administration of a single dose of recombinant human erythropoietin in pediatric cardiac surgery. Heart Surg Forum (2007) 0.97
Species and tissue differences in the expression of DPPY splicing variants. Biochem Biophys Res Commun (2006) 0.97
Urethral dysfunction in diabetic rats. J Urol (2004) 0.97
Recent advances in intravesical drug/gene delivery. Mol Pharm (2006) 0.97
Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs. BMC Urol (2006) 0.97
Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways. Urology (2005) 0.96
Effects of intravesical instillation of resiniferatoxin on bladder function and nociceptive behavior in freely moving, conscious rats. J Urol (2007) 0.95
Recent advances in the neurophysiology of stress urinary incontinence. Scand J Urol Nephrol (2005) 0.95
Effects of bladder outlet obstruction on properties of Ca2+-activated K+ channels in rat bladder. Am J Physiol Regul Integr Comp Physiol (2010) 0.94
Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation. Eur J Neurosci (2004) 0.94
Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors. J Urol (2004) 0.94
The dependence of myocardial damage on age and ischemic time in pediatric cardiac surgery. J Thorac Cardiovasc Surg (2005) 0.93
Urodynamic and immunohistochemical evaluation of intravesical capsaicin delivery using thermosensitive hydrogel and liposomes. J Urol (2004) 0.93
Differential diagnosis and treatment of impaired bladder emptying. Rev Urol (2004) 0.92
Effect of the VKORC1 genotype on warfarin dose requirements in Japanese pediatric patients. Drug Metab Pharmacokinet (2011) 0.92
Gender-based reciprocal expression of transforming growth factor-beta1 and the inducible nitric oxide synthase in a rat model of cyclophosphamide-induced cystitis. J Inflamm (Lond) (2009) 0.92
Suppression of detrusor-sphincter dysynergia by GABA-receptor activation in the lumbosacral spinal cord in spinal cord-injured rats. Am J Physiol Regul Integr Comp Physiol (2008) 0.92
Intraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects of botulinum toxin A. Eur Urol (2006) 0.92
Sustained intravesical drug delivery using thermosensitive hydrogel. Pharm Res (2004) 0.92
Functional and immunohistochemical characterization of CB1 and CB2 receptors in rat bladder. Urology (2008) 0.92
Management of pulmonary artery sling associated with tracheal stenosis. Ann Thorac Surg (2008) 0.91
Differential effects of botulinum neurotoxin A on bladder contractile responses to activation of efferent nerves, smooth muscles and afferent nerves in rats. J Urol (2012) 0.91
Effects of modified ultrafiltration on coagulation factors in pediatric cardiac surgery. Surg Today (2002) 0.91
Intravesical liposome administration--a novel treatment for hyperactive bladder in the rat. Urology (2003) 0.91
Induction of apoptosis in human bladder cancer cells by green tea catechins. Biomed Res (2009) 0.91
Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens. World J Urol (2012) 0.90
Neurotrophins as regulators of urinary bladder function. Nat Rev Urol (2012) 0.90
Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial. J Spinal Cord Med (2003) 0.90
Activity of different phospholipids in attenuating hyperactivity in bladder irritation. BJU Int (2007) 0.90
Suppression of detrusor overactivity in rats with bladder outlet obstruction by a type 4 phosphodiesterase inhibitor. BJU Int (2006) 0.89
Improvement in erectile dysfunction after neurotrophic factor gene therapy in diabetic rats. J Urol (2005) 0.89
Neurophysiology of lower urinary tract function and dysfunction. Rev Urol (2003) 0.89
The improvement of hypoxia correlates with neuroanatomic and developmental outcomes: comparison of midterm outcomes in infants with transposition of the great arteries or single-ventricle physiology. J Thorac Cardiovasc Surg (2011) 0.89
Ex vivo biomechanical properties of the female urethra in a rat model of birth trauma. Am J Physiol Renal Physiol (2006) 0.88
Hyperexcitability of bladder afferent neurons associated with reduction of Kv1.4 α-subunit in rats with spinal cord injury. J Urol (2013) 0.88
Myocardin and microRNA-1 modulate bladder activity through connexin 43 expression during post-natal development. J Cell Physiol (2013) 0.88
Effects of IP-751, ajulemic acid, on bladder overactivity induced by bladder irritation in rats. Urology (2007) 0.87
Suppression of detrusor-sphincter dyssynergia by herpes simplex virus vector mediated gene delivery of glutamic acid decarboxylase in spinal cord injured rats. J Urol (2010) 0.87
Uroplakin III-delta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis. J Urol (2007) 0.87
Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan. J Crohns Colitis (2011) 0.87
Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity. Urology (2003) 0.87